BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33846795)

  • 1. SEC61G is upregulated and required for tumor progression in human kidney cancer.
    Meng H; Jiang X; Wang J; Sang Z; Guo L; Yin G; Wang Y
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
    Ma J; He Z; Zhang H; Zhang W; Gao S; Ni X
    Cell Death Dis; 2021 May; 12(6):550. PubMed ID: 34039955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G.
    Han B
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10354-10362. PubMed ID: 31841189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEC61G plays an oncogenic role in hepatocellular carcinoma cells.
    Gao H; Niu W; He Z; Gao C; Peng C; Niu J
    Cell Cycle; 2020 Dec; 19(23):3348-3361. PubMed ID: 33171060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEC61G Promotes Cervical Cancer Proliferation by Activating MAPK Signaling Pathway.
    Fan Y; Wang Y; Liu F; Wang H; Li Q
    Dis Markers; 2022; 2022():7016079. PubMed ID: 36092956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
    Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
    Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma.
    Shi Y; Liang Y; Wang W; Zhang G
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2039-2048. PubMed ID: 34173014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
    Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
    Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEC61G participates in endoplasmic reticulum stress by interacting with CREB3 to promote the malignant progression of lung adenocarcinoma.
    Zhang Q; Guo Z
    Oncol Lett; 2022 Jul; 24(1):233. PubMed ID: 35720482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
    Zhang J; Zhang K; Hou Y
    Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High
    Liang L; Huang Q; Gan M; Jiang L; Yan H; Lin Z; Zhu H; Wang R; Hu K
    J Cancer; 2021; 12(13):3887-3899. PubMed ID: 34093796
    [No Abstract]   [Full Text] [Related]  

  • 14. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
    Zeng M; Li B; Yang L; Guan Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer.
    Sun JG; Li XB; Yin RH; Li XF
    Mol Med Rep; 2020 Dec; 22(6):4567-4578. PubMed ID: 33173977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
    Hu B; Zhu X; Lu J
    Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
    Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
    Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.